Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Invasive drug delivery.

Ulrike Blömer1, Arnold Ganser, Michaela Scherr

  • 1Department of Hematology and Oncology, Medical School Hannover, Carl-Neuber-Str. 1,30625 Hannover, Germany.

Advances in Experimental Medicine and Biology
|February 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid and Reproducible Karyotyping with Long Read Sequencing in AML Patients.

Blood advances·2026
Same author

Hematology in times of crisis: Lessons learned and strategic priorities from the EHA-ASH Joint Workshop on Ukraine.

HemaSphere·2026
Same author

A phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

Blood·2026
Same author

Outcomes of allogeneic hematopoietic stem cell transplantation from different donor types in primary refractory acute myeloid leukemia: a report from the ALWP of the EBMT.

Bone marrow transplantation·2025
Same author

Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients.

Leukemia·2025
Same author

Tailoring intensive and less-intensive treatment in acute myeloid leukemia.

Seminars in hematology·2025

Gene therapy offers new ways to treat brain diseases by delivering therapeutic genes directly to the central nervous system (CNS). Lentiviral vectors are highlighted as the most effective tool for this gene delivery in the CNS.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biotechnology

Background:

  • The central nervous system (CNS) is a key target for neurological disease therapies.
  • The blood-brain barrier presents challenges for systemic drug delivery but offers immune privilege.
  • Neurosurgical techniques enable direct gene delivery to the CNS.

Purpose of the Study:

  • To review current tools for therapeutic agent delivery in the CNS.
  • To evaluate viral vectors for gene delivery, focusing on their efficiency and stability.
  • To identify lentiviral vectors as a superior option for CNS gene therapy.

Main Methods:

  • Overview of synthetic and viral vectors for gene delivery.
  • Discussion of limitations of adenoviral and adeno-associated viral vectors.

Related Experiment Videos

  • Focus on lentiviral vectors, including HIV-1 based constructs.

    • Main Results:

    • Viral vectors are efficient and stable for transgene delivery.
    • Lentiviral vectors overcome limitations of earlier viral vectors, such as immune response and infection of non-dividing cells.
    • Lentiviral vectors provide long-term, stable transgene expression in vivo.

    Conclusions:

    • Lentiviral vectors are the most efficient tool for gene delivery in the CNS.
    • They offer stable, long-term transgene expression with minimal immune response.
    • This makes them highly promising for future CNS therapeutic strategies.